Yüklüyor......
Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease
BACKGROUND: Diabetes is the commonest cause of chronic kidney disease (CKD). Both conditions commonly co‐exist. Glucometabolic changes and concurrent dialysis in diabetes and CKD make glucose‐lowering challenging, increasing the risk of hypoglycaemia. Glucose‐lowering agents have been mainly studied...
Kaydedildi:
| Yayımlandı: | Cochrane Database Syst Rev |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley & Sons, Ltd
2018
|
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6513625/ https://ncbi.nlm.nih.gov/pubmed/30246878 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011798.pub2 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|